The ROS production was inhibited by Rh1 treatment in Ang II-stimulated RASMCs; however, Rh1 promoted an excessive production of ROS in MCF-7 breast cancer cells, killing these cells, which was demonstrated in our previous report [17]. Here, AGT is linked to breast carcinoma.